Q2 2022 Rain Therapeutics Inc Earnings Call Transcript
Good day and welcome to the Rain Therapeutics second-quarter 2022 earnings conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to Bob Yedid. Please go ahead.
Thank you, operator, and good afternoon, everyone. With me today on the call are Avanish Vellanki, Chief Executive Officer of Rain Therapeutics; and Nelson Cabatuan, SVP of Finance. During today's call, Avanish will provide an overall business update including Rain's clinical programs and research efforts, and Nelson will review the financials.
Before we begin, I would like to remind you that statements made during this conference call that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon Rain's current expectations and involve assumptions that may never materialize or may prove to be incorrect.
Actual results may differ materially from those anticipated
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
